10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $866,250 | +267.1% | 21,000 | +577.4% | 0.16% | +258.7% |
| Q1 2022 | $236,000 | -48.9% | 3,100 | 0.0% | 0.05% | -54.5% |
| Q4 2021 | $462,000 | +2.4% | 3,100 | 0.0% | 0.10% | +2.0% |
| Q3 2021 | $451,000 | -25.7% | 3,100 | 0.0% | 0.10% | -21.4% |
| Q2 2021 | $607,000 | -67.0% | 3,100 | -85.0% | 0.13% | -73.1% |
| Q2 2020 | $1,840,000 | -4.0% | 20,600 | -33.0% | 0.47% | -9.1% |
| Q1 2020 | $1,916,000 | -39.1% | 30,750 | -25.5% | 0.52% | -48.5% |
| Q4 2019 | $3,145,000 | +21.1% | 41,250 | -19.9% | 1.00% | +36.2% |
| Q3 2019 | $2,596,000 | – | 51,500 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |